NO20062229L - Middel og fremgangsmate for a behandle cancer omfattende strontium, aminosyre(r) og mineralagent(er) - Google Patents
Middel og fremgangsmate for a behandle cancer omfattende strontium, aminosyre(r) og mineralagent(er)Info
- Publication number
- NO20062229L NO20062229L NO20062229A NO20062229A NO20062229L NO 20062229 L NO20062229 L NO 20062229L NO 20062229 A NO20062229 A NO 20062229A NO 20062229 A NO20062229 A NO 20062229A NO 20062229 L NO20062229 L NO 20062229L
- Authority
- NO
- Norway
- Prior art keywords
- agent
- strontium
- amino acid
- treating cancer
- mineral
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 4
- 201000011510 cancer Diseases 0.000 title abstract 4
- 239000003795 chemical substances by application Substances 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- 229910052712 strontium Inorganic materials 0.000 title abstract 2
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 title abstract 2
- 150000001413 amino acids Chemical class 0.000 title 2
- 229910052500 inorganic mineral Inorganic materials 0.000 title 1
- 239000011707 mineral Substances 0.000 title 1
- 238000011321 prophylaxis Methods 0.000 abstract 3
- 238000011282 treatment Methods 0.000 abstract 3
- 239000008177 pharmaceutical agent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Inorganic Chemistry (AREA)
- Nutrition Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Oppfinnelsen vedrører behandling og profylakse av cancer. Oppflrmelsen vedrører spesielt et farmasøytisk middel omfattende strontium, aminosyre(r) og mineralelement(er) og dets anvendelse i fremstillingen av et middel nyttig for behandling og profylakse av cancer. Oppflrmelsen vedrører også en fremgangsmåte for behandling og profylakse av cancer.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03103850A EP1523985B1 (en) | 2003-10-17 | 2003-10-17 | Non-radioactive strontium agent for treating cancer |
PCT/FI2004/000618 WO2005037295A1 (en) | 2003-10-17 | 2004-10-15 | Agent and method for treating cancer comprising strontium, amino acid(s) and mineral agent(s) |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20062229L true NO20062229L (no) | 2006-05-18 |
Family
ID=34354592
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20062229A NO20062229L (no) | 2003-10-17 | 2006-05-18 | Middel og fremgangsmate for a behandle cancer omfattende strontium, aminosyre(r) og mineralagent(er) |
Country Status (11)
Country | Link |
---|---|
US (2) | US20070031476A1 (no) |
EP (1) | EP1523985B1 (no) |
CN (1) | CN1886143B (no) |
AT (1) | ATE460168T1 (no) |
AU (1) | AU2004281559B2 (no) |
DE (1) | DE60331654D1 (no) |
DK (1) | DK1523985T3 (no) |
ES (1) | ES2342461T3 (no) |
NO (1) | NO20062229L (no) |
RU (1) | RU2363479C2 (no) |
WO (1) | WO2005037295A1 (no) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI122450B (fi) * | 2007-12-28 | 2012-01-31 | Neurofood Ab Oy | Koostumus steriilin inflammaation hoitoon |
MX358716B (es) * | 2010-08-18 | 2018-08-24 | Colgate Palmolive Company Star | Composiciones estables para el cuidado bucal que comprenden un aminoácido básico , una sal de estroncio y una fuente de ion fluoruro y usos de las mismas. |
FI123756B (fi) * | 2010-09-21 | 2013-10-31 | Neurofood Ab Oy | Parannettu lisäravinne syövän hoitamiseksi tai ennaltaehkäisemiseksi |
EP2530068A1 (en) | 2011-05-31 | 2012-12-05 | Lacer, S.A. | New strontium salts, synthesis and use thereof in the treatment of osteoporosis |
WO2013013003A1 (en) * | 2011-07-21 | 2013-01-24 | Emory University | Methods for treating inflamatory conditions and states, and cancers by antagonizing nf-kb activation |
PT3173382T (pt) * | 2014-07-21 | 2023-03-10 | Oxolife Sl | Sais de tungsténio (vi) utilizados para tratar infertilidade, para estimular a fertilidade e a reprodução normal num mamífero fêmea não diabético, e para melhorar a eficácia das técnicas de reprodução assistida |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB602029A (en) * | 1942-04-17 | 1948-05-19 | Western Condensing Co | Improvements in or relating to process of manufacturing a vitamin concentrate |
GB602209A (en) * | 1945-06-13 | 1948-05-21 | Norton Co | Hydraulic table reciprocating mechanism |
EP0366869A3 (en) * | 1988-10-17 | 1991-06-12 | Lycon Ag | Bacteriostatic, bactericidal and antifungal composition and methods of use thereof |
CN1082845A (zh) | 1992-12-21 | 1994-03-02 | 颜怀玮 | 营养平衡强化型矿泉水及制造方法 |
CN1053091C (zh) * | 1993-03-13 | 2000-06-07 | 彭建汉 | 天然竹汁保健饮料 |
CN1113720A (zh) * | 1994-05-24 | 1995-12-27 | 云南智成科技实业公司 | 保健液及其生产方法 |
US5650316A (en) * | 1994-06-06 | 1997-07-22 | Research Development Foundation | Uses of triplex forming oligonucleotides for the treatment of human diseases |
EP0737471A3 (fr) * | 1995-04-10 | 2000-12-06 | L'oreal | Utilisation d'un sel d'une métal alcalino-terreux comme inhibiteur de TNF-alpha dans une composition unique et composition obtenue |
FR2740341B1 (fr) * | 1995-10-26 | 1997-12-19 | Oreal | Utilisation de sel de lanthanide, d'etain, de zinc, de manganese, d'yttrium, de cobalt, de baryum, de strontium dans une composition pour la peau |
CN1153053A (zh) * | 1995-12-28 | 1997-07-02 | 汪贵昌 | 一种治疗肿瘤的克癌灵中药 |
US5916143A (en) * | 1996-04-30 | 1999-06-29 | Apple; Marc G. | Brachytherapy catheter system |
WO2000007607A1 (en) * | 1998-08-04 | 2000-02-17 | Kosbab, John, V. | Nutrient and therapeutic compositions for the treatment of cancer |
CA2382262C (en) | 1999-08-30 | 2004-12-07 | Ocean Nutrition Canada Ltd. | A nutritional supplement for lowering serum triglyceride and cholesterol levels |
DE60004710T2 (de) * | 1999-12-09 | 2004-07-08 | Biosyntech Canada Inc., Laval | Mineral-polymer hybrid-zusammensetzung |
US6456680B1 (en) * | 2000-03-29 | 2002-09-24 | Tci Incorporated | Method of strontium-89 radioisotope production |
NO20014746D0 (no) * | 2001-09-28 | 2001-09-28 | Clas M Kjoelberg | Smertelindrende middel |
US20040001835A1 (en) * | 2002-03-04 | 2004-01-01 | Medimmune, Inc. | Prevention or treatment of cancer using integrin alphavbeta3 antagonists in combination with other agents |
-
2003
- 2003-10-17 EP EP03103850A patent/EP1523985B1/en not_active Expired - Lifetime
- 2003-10-17 AT AT03103850T patent/ATE460168T1/de not_active IP Right Cessation
- 2003-10-17 DK DK03103850.8T patent/DK1523985T3/da active
- 2003-10-17 DE DE60331654T patent/DE60331654D1/de not_active Expired - Lifetime
- 2003-10-17 ES ES03103850T patent/ES2342461T3/es not_active Expired - Lifetime
-
2004
- 2004-10-15 WO PCT/FI2004/000618 patent/WO2005037295A1/en active Application Filing
- 2004-10-15 US US10/575,752 patent/US20070031476A1/en not_active Abandoned
- 2004-10-15 AU AU2004281559A patent/AU2004281559B2/en not_active Ceased
- 2004-10-15 RU RU2006115785/15A patent/RU2363479C2/ru not_active IP Right Cessation
- 2004-10-15 CN CN2004800350230A patent/CN1886143B/zh not_active Expired - Fee Related
-
2006
- 2006-05-18 NO NO20062229A patent/NO20062229L/no not_active Application Discontinuation
-
2009
- 2009-11-30 US US12/626,980 patent/US8703211B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
RU2006115785A (ru) | 2007-11-27 |
EP1523985B1 (en) | 2010-03-10 |
EP1523985A1 (en) | 2005-04-20 |
RU2363479C2 (ru) | 2009-08-10 |
CN1886143B (zh) | 2011-04-06 |
US20070031476A1 (en) | 2007-02-08 |
US8703211B2 (en) | 2014-04-22 |
AU2004281559B2 (en) | 2010-04-01 |
ATE460168T1 (de) | 2010-03-15 |
US20100074968A1 (en) | 2010-03-25 |
ES2342461T3 (es) | 2010-07-07 |
DE60331654D1 (de) | 2010-04-22 |
AU2004281559A1 (en) | 2005-04-28 |
DK1523985T3 (da) | 2010-05-31 |
CN1886143A (zh) | 2006-12-27 |
WO2005037295A1 (en) | 2005-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO2020031I1 (no) | kobimetinib, inklusive farmasøytisk akseptable salter og solvater, særlig kobimetinib hemifumarat | |
BRPI0307351B8 (pt) | composto, composição farmacêutica, uso de um composto, e, processo para preparar um composto | |
BRPI0607402A2 (pt) | uso de inibidores de pde7 para o tratamento de dor neuropática | |
CY1109422T1 (el) | Παραγωγα φαιναιθανολαμινης για θεραπεια ασθενειων του αναπνευστικου | |
UA88645C2 (ru) | Гетероарильные соединения как бета-миметики для лечения заболеваний дыхательных путей | |
MXPA03009840A (es) | Derivados de fenilurea sustituidos con carboxamida y metodo para la produccion de los mismos como farmacos. | |
BR0307058A (pt) | N-óxidos de derivados de n-fenil-2-pirimidina-amina | |
ATE408601T1 (de) | Fredericamycin-derivate | |
WO2004093803A3 (en) | Photochemotherapeutic compounds for use in treatment of pin1-associated states | |
EP1362127A4 (en) | SERPIN-BASED MEDICINAL PRODUCTS FOR THE TREATMENT OF HIV INFECTION AND THE USE THEREOF | |
PH12013500123A1 (en) | Hemiasterlin derivatives and uses thereof | |
TW200716224A (en) | Method of indentifying therapeutic targets for the treatment of vulvovaginal atrophy | |
ATE396174T1 (de) | Hydroxyalkylaminderivate als beta-secretase- inhibitoren und deren verwendung zur behandlung der alzheimerschen krankheit oder ähnlicher krankheiten | |
DK1545537T3 (da) | Alfa-7-nikotinreceptoragonister og statiner i kombination | |
MY141528A (en) | Anilinopyrazole derivatives useful for the treatment of diabetes | |
NO20062229L (no) | Middel og fremgangsmate for a behandle cancer omfattende strontium, aminosyre(r) og mineralagent(er) | |
DK1648484T3 (da) | Fremgangsmåde til behandling af arthritis-tilstande | |
UA83821C2 (ru) | Производные бензолсульфонамидов, способ их получения и их применение для лечения воспалительных заболеваний и утоления боли | |
BR0312470A (pt) | Composto, uso do mesmo, composição farmacêutica, método de tratar e/ou prevenir câncer, e, processo para preparar o composto | |
DE602006006915D1 (de) | Marrubin und zusammensetzung zur verringerung von schnarchen, verpackung und verfahren | |
MXPA06007007A (es) | Derivados de prolina usados como ingredientes farmaceuticos activos para el tratamiento de tumores. | |
HK1074840A1 (en) | Novel dithiolopyrrolones with therapeutic activity | |
BR0111785A (pt) | Composições e métodos para tratamento de candidìase | |
BRPI0411168A (pt) | composição para o tratamento dos cabelos, usos de uma composição e método de tratamento dos cabelos | |
BRPI0408238A (pt) | anticorpo, método de detectar cáncer, conjunto para detecção de cáncer, e, composição farmacêutica para tratar cáncer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |